Functional role of the KLF6 tumour suppressor gene in gastric cancer

European Journal of Cancer

Volumn 45, Issue 4, 2009, Pages 666-676

  Sangodkar, Jaya ^a   Shi, Jiayan ^a   DiFeo, Analisa ^a   Schwartz, Rachel ^a   Bromberg, Romina ^a   Choudhri, Aisha ^a   McClinch, Kim ^a   Hatami, Raheleh ^a   Scheer, Elias ^a   Kremer Tal, Sigal ^a   Martignetti, John A ^a   Hui, Alex ^b   Leung, W K ^b   Friedman, Scott L ^a   Narla, Goutham ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gastric cancer; Kruppel like; Loss of heterozygosity; Somatic mutation; Tumour suppressor gene

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; KRUPPEL LIKE FACTOR 6;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MISSENSE MUTATION; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; SOMATIC MUTATION; STOMACH CANCER; STOMACH TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WILD TYPE;

AGED; ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, INBRED BALB C; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 60149105042     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.11.009     Document Type: Article

References (33)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics. CA Cancer J Clin 55 (2005) 10-30
2. Ushijima T., and Sasako M. Focus on gastric cancer. Cancer Cell 2 (2004) 121-125
3. Black A.R., Black J.D., and Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188 (2001) 143-160
4. Narla G., Heath K.E., Reeves H.L., et al. KLF6, a candidate tumour suppressor gene mutated in prostate cancer. Science 294 (2001) 2563-2566
5. Chen C., Hyytinen E.R., Sun X., et al. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 162 (2003) 1349-1354
6. Reeves H.L., Narla G., Ogunbiyi O., et al. Kruppel-like factor 6 (KLF6) is a tumour suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 126 (2004) 1090-1093
7. Cho Y.G., Choi B.J., Kim C.J., et al. Genetic alterations of the KLF6 gene in colorectal cancers. APMIS 114 (2006) 458-464
8. Ito G., Uchiyama M., Kondo M., et al. Kruppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 64 (2004) 3838-3843
9. DiFeo A., Feld L., Rodriguez E., et al. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res 68 (2008) 965-970
10. Cho Y.G., Kim C.J., Park C.H., et al. Genetic alterations of the KLF6 gene in gastric cancer. Oncogene 24 (2005) 4588-4590
11. Jeng Y.M., and Hsu H.C. KLF6, a putative tumour suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 105 (2003) 625-629
12. Camacho-Vanegas O., Narla G., Teixeira M.S., et al. Functional inactivation of the KLF6 tumour suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma. Int J Cancer 121 (2007) 1390-1395
13. Chen H.K., Liu X.Q., Lin J., Chen T.Y., Feng Q.S., and Zeng Y.X. Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng 21 (2002) 1047-1050
14. Kremer-Tal S., Reeves H.L., Narla G., et al. Frequent inactivation of the tumour suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 40 (2004) 1047-1052
15. Pan X.C., Chen Z., Chen F., Chen X.H., Jin H.Y., and Xu X.Y. Inactivation of the tumour suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas. J Zhejiang Univ Sci B 7 (2006) 830-836
16. Song J., Kim C.J., Cho Y.G., et al. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma. J Gastroenterol Hepatol 21 (2006) 1286-1289
17. Kremer-Tal S., Narla G., Chen Y., et al. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol 46 (2007) 645-654
18. Hartel M., Narla G., Wente M.N., et al. Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Euro J Cancer 44 (2008) 1895-1903
19. DiFeo A., Narla G., Hirshfeld J., et al. Role of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res 12 (2006) 3730-3739
20. Muhlbauer K.R., Grone H.J., Ernst T., et al. Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. Brit J Cancer 89 (2003) 687-690
21. Lièvre A., Landi B., Côté J.F., et al. Absence of mutation in the putative tumour-suppressor gene KLF6 in colorectal cancers. Oncogene 48 (2005) 7253-7256
22. Boyault S., Herault A., Balabaud C., and Zucman-Rossi J. Absence of KLF6 gene mutation in 71 hepatocellular carcinomas. Hepatology 41 (2005) 681-682
23. Glinsky G.V., Glinskii A.B., Stephenson A.J., Hoffman R.M., and Gerald W.I. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 113 (2004) 913-923
24. Singh D., Febbo P.G., Ross K., et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2 (2002) 203-209
25. Narla G., Difeo A., Fernandez Y., et al. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. J Clin Invest 118 (2008) 2711-2721
26. Kettunen E., Anttila S., Seppänen J.K., et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 149 (2004) 98-106
27. DiFeo A., Narla G., Camacho-Vanegas O., et al. E-cadherin is a novel transcriptional target of the KLF6 tumour suppressor. Oncogene 44 (2006) 6026-6031
28. Benzeno S., Narla G., Allina J., et al. Cyclin-dependent kinase inhibition by the KLF6 tumour suppressor protein through interaction with cyclin D1. Cancer Res 64 (2004) 3885-3891
29. Slavin D.A., Koritschoner N.P., Prieto C.C., López-Díaz F.J., Chatton B., and Bocco J.L. A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-jun proto-oncoprotein function. Oncogene 23 (2004) 8196-8205
30. Narla G., DiFeo A., Reeves H.L., et al. A germline DNA polymorphism associated with increased prostate cancer risk enhances alternative splicing of the KLF6 tumour suppressor gene. Cancer Res 65 (2005) 1213-1222
31. Narla G., Difeo A., Reeves H.L., et al. Targeted Inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res 65 (2005) 5761-5768
32. Yamashita K., Upadhyay S., and Osada M. Pharmacologic unmasking of epigenetically silenced tumour suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2 (2002) 485-495
33. Narla G., Kremer-Tal S., Nobuyuki M., et al. In vivo regulation of p21 by the KLF6 tumour suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene 26 (2007) 4428-4434